Home
Guidelines
Pathogens
Antimicrobials
Staphyloccocus aureus
MRSA Risk Factors:
Evidence of MRSA infection elsewhere
Nasal colonization with MRSA
Injection drug use
Streptococcus pyogenes (Group A β-hemolytic streptococci)
Enterobacteriaceae
Haemophilus influenzae
Streptococcus pneumoniae
Cefazolin 35-50mg/kg IV Q8H Max 6g/day, 2g/dose
Vancomycin 15 mg/kg IV Q6H